» Articles » PMID: 34191680

COVID-19 Vaccine Hesitancy - Reasons and Solutions to Achieve a Successful Global Vaccination Campaign to Tackle the Ongoing Pandemic

Overview
Date 2021 Jun 30
PMID 34191680
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive further outbreaks. Vaccine hesitancy is one of the major threats that directly impact global health as it challenges our ability to eradicate infectious diseases and achieve significant herd immunity through vaccination. One of the strategies to counter vaccine hesitancy is to follow a multisectoral approach that involves the collaboration between various stakeholders, such as government, private companies, religious groups, and other agencies, to leverage the knowledge, expertise, and resources, thereby enabling the creation of longstanding public trust of vaccines.

Citing Articles

Trust in official information as a key predictor of COVID-19 vaccine acceptance: evidence from a Czech longitudinal survey study.

Grygarova D, Kozeny J, Tisanska L, Havlik M, Horacek J BMC Public Health. 2025; 25(1):770.

PMID: 40001023 PMC: 11853922. DOI: 10.1186/s12889-025-21988-x.


A survey of perceptions and behavioural responses towards the COVID-19 pandemic in South Africa.

Silubonde T, Draper C, Norris S Afr J Prim Health Care Fam Med. 2025; 17(1):e1-e8.

PMID: 39935119 PMC: 11830832. DOI: 10.4102/phcfm.v17i1.4702.


Pediatric asthma and COVID-19 vaccination: unveiling patterns of hesitancy and acceptance.

Tavakol M, Gharagozlou S, Abbasi M, Zamani Z, Gharagozlou M Ther Adv Vaccines Immunother. 2024; 12:25151355241297874.

PMID: 39544988 PMC: 11561997. DOI: 10.1177/25151355241297874.


[Refusal and hesitation regarding vaccination against COVID-19 in Douala, Cameroon].

Bita Fouda A, Kengne V, Adiogo D, Manga L Pan Afr Med J. 2024; 48:61.

PMID: 39355714 PMC: 11444086. DOI: 10.11604/pamj.2024.48.61.39880.


Efficacy and safety of a novel antiviral herbal preparation in ICU-admitted patients with COVID-19: A phase III double-blinded controlled trial.

Avicenna J Phytomed. 2024; 14(2):215-228.

PMID: 38966633 PMC: 11221769. DOI: 10.22038/AJP.2023.23259.


References
1.
Dror A, Eisenbach N, Taiber S, Morozov N, Mizrachi M, Zigron A . Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020; 35(8):775-779. PMC: 8851308. DOI: 10.1007/s10654-020-00671-y. View

2.
Hooper M, Napoles A, Perez-Stable E . No Populations Left Behind: Vaccine Hesitancy and Equitable Diffusion of Effective COVID-19 Vaccines. J Gen Intern Med. 2021; 36(7):2130-2133. PMC: 7985226. DOI: 10.1007/s11606-021-06698-5. View

3.
Grossman V . The COVID-19 Vaccine: Why the Hesitancy?. J Radiol Nurs. 2021; 40(2):116-119. PMC: 7951560. DOI: 10.1016/j.jradnu.2021.02.011. View

4.
Marco-Franco J, Pita-Barros P, Vivas-Orts D, Gonzalez-de-Julian S, Vivas-Consuelo D . COVID-19, Fake News, and Vaccines: Should Regulation Be Implemented?. Int J Environ Res Public Health. 2021; 18(2). PMC: 7830913. DOI: 10.3390/ijerph18020744. View

5.
Lin C, Tu P, Beitsch L . Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines (Basel). 2021; 9(1). PMC: 7823859. DOI: 10.3390/vaccines9010016. View